Back to today’s briefing

Story perspectives

Lawmakers Urge FDA to Combat Counterfeit Weight-Loss Drugs

7/26/2025

23 3

Summary

Story summary

More than 80 bipartisan lawmakers are calling on the FDA to crack down on compounding pharmacies peddling counterfeit weight-loss drugs, as shortages of popular medications from Novo Nordisk and Eli Lilly escalate. These illegal drugs pose serious risks to patient safety, prompting concern. Meanwhile, shares of telehealth company Hims & Hers fell, despite its focus on compounding GLP-1s.

1 of 1

Story summary

More than 80 bipartisan lawmakers are calling on the FDA to crack down on compounding pharmacies peddling counterfeit weight-loss drugs, as shortages of popular medications from Novo Nordisk and Eli Lilly escalate. These illegal drugs pose serious risks to patient safety, prompting concern. Meanwhile, shares of telehealth company Hims & Hers fell, despite its focus on compounding GLP-1s.